University of Colorado Cancer Center Associate Director of Clinical Research, Christopher Lieu, MD, is bringing his wealth of expertise and dedication to a new role as the Vice Chair of the National Comprehensive Cancer Network (NCCN).
For the past thirteen years, Lieu has been an investigator on numerous CU Cancer Center studies, including taking the lead on early-onset colorectal cancer research. Lieu received the National Cancer Institute Cancer Clinical Investigator Team Leadership Award in 2017 and his work focuses on Gastrointestinal Cancers, Drug Development (Experimental Therapeutics), Clinical Trials, and Translational Research.
His journey to leadership within the NCCN reflects a deep commitment to advancing patient care, education, and research in oncology. As Vice-Chair of the NCCN Board of Directors, Lieu will play a pivotal role in shaping the future of cancer care globally.
The NCCN is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. They develop evidence-based guidelines for oncology care, provide education and training programs for healthcare professionals, and conduct research to improve cancer treatment and outcomes.
We had the privilege of discussing with Lieu the significance of NCCN membership, his motivation for pursuing a leadership role, and the impact of his appointment on the CU Cancer Center's mission of innovation and leadership in cancer care and research.